Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recurrent ventricular tachycardia in cardiac sarcoidosis: usefulness of fluorodeoxyglucose positron emission tomography for adequate management of corticoid therapy after placement of an implantable cardioverter defibrillator.

× No keyword cloud information.

13 in total

1. Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis.

Authors: N Takeda; I Yokoyama; Y Hiroi; M Sakata; T Harada; F Nakamura; Y Murakawa; R Nagai
Journal: Circulation Date: 2002-03-05 Impact factor: 29.690

2. Suppression of implantable cardioverter defibrillator therapy during magnetic resonance imaging.

Authors: Jan Nemec
Journal: J Cardiovasc Electrophysiol Date: 2006-04

Review 3. Cardiac sarcoidosis.

Authors: Abdul R Doughan; Byron R Williams
Journal: Heart Date: 2006-02 Impact factor: 5.994

4. Sarcoidosis presenting with tachy- and brady-arrhythmias.

Authors: Neil Swanson; Martin Goddard; Gerry McCann; G André Ng
Journal: Europace Date: 2007-01-11 Impact factor: 5.214

5. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.

Authors: Shinji Ishimaru; Ichizo Tsujino; Toshiki Takei; Eriko Tsukamoto; Shinji Sakaue; Mitsunori Kamigaki; Naofumi Ito; Hiroshi Ohira; Daisuke Ikeda; Nagara Tamaki; Masaharu Nishimura
Journal: Eur Heart J Date: 2005-04-04 Impact factor: 29.983

6. Sudden death caused by cardiac sarcoidosis in childhood.

Authors: Christopher Duke; Eric Rosenthal
Journal: J Cardiovasc Electrophysiol Date: 2002-09

7. Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques.

Authors: C Pandya; R C Brunken; P Tchou; P Schoenhagen; D A Culver
Journal: Eur Respir J Date: 2007-02 Impact factor: 16.671

8. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Authors: Wataru Okumura; Tsutomu Iwasaki; Takuji Toyama; Tatsuya Iso; Masashi Arai; Noboru Oriuchi; Keigo Endo; Tomoyuki Yokoyama; Tadashi Suzuki; Masahiko Kurabayashi
Journal: J Nucl Med Date: 2004-12 Impact factor: 10.057

9. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.

Authors: Jan-Peter Smedema; Gabriel Snoep; Marinus P G van Kroonenburgh; Robert-Jan van Geuns; Willem R M Dassen; Anton P M Gorgels; Harry J G M Crijns
Journal: J Am Coll Cardiol Date: 2005-04-25 Impact factor: 24.094

10. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device.

Authors: S L Winters; M Cohen; S Greenberg; B Stein; J Curwin; E Pe; J A Gomes
Journal: J Am Coll Cardiol Date: 1991-10 Impact factor: 24.094

3 in total

Recurrent ventricular tachycardia in cardiac sarcoidosis: usefulness of fluorodeoxyglucose positron emission tomography for adequate management of corticoid therapy after placement of an implantable cardioverter defibrillator.